16 February 2009
Seattle, Wash. – In Alzheimer’s disease the brain accumulates a molecule called A-beta (Aβ) that can be quite toxic to brain cells. Many researchers believe that finding ways to clear Aβ may be a key to treatment or prevention of Alzheimer’s disease.
22 January 2009
Amsterdam, The Netherlands – A growing body of evidence demonstrates that we can take steps to delay age-related cognitive decline, including in some cases that which accompanies Alzheimer’s disease, according to a study published in the January 20
15 January 2009
Amsterdam, The Netherlands and Sun City, AZ, USA – Researchers at Banner Health’s Sun Health Research Institute have uncovered evidence that Alzheimer’s disease (AD) may be clinically confirmed in patients with apolipoprotein E2 homozygote.
14 January 2009
Stockholm, Sweden -- Midlife coffee drinking can decrease the risk of dementia/Alzheimer's disease (AD) later in life.
15 December 2008
CSIRO Scientists Announce Alzheimer's Disease Breakthrough
15 December 2008
Amsterdam, The Netherlands–Very few species spontaneously develop the cognitive, behavioral and neuropathological symptoms of Alzheimer’s disease (AD), yet AD research must progress at a more rapid pace than the rate of human aging.
1 December 2008
Amsterdam, The Netherlands -- A study published in the November issue of the Journal of Alzheimer’s Disease provides an insight into normal, physiological levels and association between proteins involved in development of Alzheimer’s disease.
24 November 2008
Amsterdam, The Netherlands and Sun City, AZ, USA -- A study published in the November issue of the Journal of Alzheimer’s Disease (Volume 15:3) suggests the reliability of the Alzheimer’s Disease Assessment Scale – Cognitive (ADAS-Cog) may vary and possess
17 November 2008
Atlanta—With millions of baby boomers entering late adulthood, the number of patients with Alzheimer’s disease (AD) is expected to drastically rise over the next several decades.
22 October 2008
Amsterdam – The past 25 years have seen an explosion of scientific investigations into the basic neurobiology of Alzheimer's disease (AD). Unfortunately, the gap between bench and bedside remains as vast as ever.